Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 27 Feb 2026 07:30 CET |
VALLOUREC | Vallourec Fourth Quarter 2025 Results | 60101030 Oil Equipment and Services | Income |
| 27 Feb 2026 07:30 CET |
VALLOUREC | Résultats du Quatrième Trimestre 2025 | 60101030 Oil Equipment and Services | Income |
| 27 Feb 2026 07:01 CET |
BIOMERIEUX | bioMérieux – 2025 Financial Results | 20102010 Medical Equipment | Other subject |
| 27 Feb 2026 07:01 CET |
BIOMERIEUX | bioMérieux – Résultats annuels au 31 décembre 2025 | 20102010 Medical Equipment | Other subject |
| 26 Feb 2026 23:55 CET |
SHOWROOMPRIVE | RÉSULTAT DU 1ER SEMESTRE 2025 | 40401020 Apparel Retailers | Sales, Income, Commercial results |
| 26 Feb 2026 22:55 CET |
STMICROELECTRONICS | STMicroelectronics Publishes its 2025 Annual Report Form 20-F | 10102010 Semiconductors | Corporate life |
| 26 Feb 2026 22:55 CET |
STMICROELECTRONICS | STMicroelectronics publie son formulaire 20-F pour l’année 2025 | 10102010 Semiconductors | Corporate life |
| 26 Feb 2026 22:14 CET |
INVENTIVA | Inventiva participera à quatre conférences investisseurs en mars | 20103010 Biotechnology | - |
| 26 Feb 2026 22:14 CET |
INVENTIVA | Inventiva to Participate in Four Upcoming March Investor Conferences | 20103010 Biotechnology | - |
| 26 Feb 2026 22:00 CET |
INVENTIVA | Inventiva to Participate in Four Upcoming March Investor Conferences | 20103010 Biotechnology | - |
| 26 Feb 2026 22:00 CET |
INVENTIVA | Inventiva to Participate in Four Upcoming March Investor Conferences | 20103010 Biotechnology | - |
| 26 Feb 2026 21:30 CET |
GROUPE SFPI | SFPI GROUPE: publication du Chiffre d\'affaires annuel 2025 | 50101035 Building Materials: Other | Income |
| 26 Feb 2026 21:30 CET |
GROUPE SFPI | SFPI GROUP: publication of 2025 annual sales | 50101035 Building Materials: Other | Income |
| 26 Feb 2026 19:46 CET |
EDF4.5%04DEC2069 | EDF : EDF annonce le succès de son émission d’obligations senior vertes multi-tranches pour un montant nominal de 2,75 milliards d’euros | 65101015 Conventional Electricity | Corporate life |
| 26 Feb 2026 19:46 CET |
EDF4.5%04DEC2069 | EDF: EDF announces the success of its senior green multi tranche bond issue for a nominal amount of 2.75 billion euros | 65101015 Conventional Electricity | Corporate life |
| 26 Feb 2026 18:53 CET |
HITECHPROS | HITECHPROS - CHIFFRE D'AFFAIRES 2025 : 26,6M€ | 10101010 Computer Services | Commercial results |
| 26 Feb 2026 18:36 CET |
VALLOUREC | Appointment of David Clarke As New Director of Vallourec | 60101030 Oil Equipment and Services | General meeting / Board Meeting |
| 26 Feb 2026 18:36 CET |
VALLOUREC | DAVID CLARKE NOUVEL ADMINSTRATEUR DE VALLOUREC | 60101030 Oil Equipment and Services | General meeting / Board Meeting |
| 26 Feb 2026 18:30 CET |
ODIOT S.A. | GreenSome Finance reiterates its "Buy" recommendation on ODIOT S.A following its capital increase | 40204030 Luxury Items | Legal |
| 26 Feb 2026 18:30 CET |
PAREF | 2025 FULL-YEAR RESULTS | 35102000 Diversified REITs | Sales, Income, Commercial results |
| 26 Feb 2026 18:30 CET |
ODIOT S.A. | GreenSome Finance confirme sa recommandation " Achat " pour ODIOT S.A à la suite de son augmentation de capital. | 40204030 Luxury Items | Legal |
| 26 Feb 2026 18:26 CET |
CASINO GUICHARD | Casino Group Communication | 45201010 Food Retailers and Wholesalers | Other subject |
| 26 Feb 2026 18:26 CET |
CASINO GUICHARD | Communication du Groupe Casino | 45201010 Food Retailers and Wholesalers | Other subject |
| 26 Feb 2026 18:16 CET |
FERM.CASINO MUNICIPAL CANNES | Avis rectificatif du RAPPORT FINANCIER ANNUEL 2024/2025 (Format ESEF) | 40501020 Casinos and Gambling | Income |
| 26 Feb 2026 18:15 CET |
TELEPERFORMANCE | TP: 2025 Annual Results | 50205020 Professional Business Support Services | General meeting / Board Meeting |
| 26 Feb 2026 18:15 CET |
PAREF | PAREF renforce ses fondamentaux et engage son recentrage stratégique | 35102000 Diversified REITs | Sales, Income, Commercial results |
| 26 Feb 2026 18:15 CET |
TELEPERFORMANCE | TP : Résultats annuels 2025 | 50205020 Professional Business Support Services | General meeting / Board Meeting |
| 26 Feb 2026 18:06 CET |
FERM.CASINO MUNICIPAL CANNES | Avis rectificatif du RAPPORT FINANCIER ANNUEL 2024/2025 (Format PDF) | 40501020 Casinos and Gambling | Income |
| 26 Feb 2026 18:05 CET |
CLARIANE SE | Résultats annuels 2025 | 20101010 Health Care Facilities | Income |
| 26 Feb 2026 18:05 CET |
CLARIANE SE | Full-year 2025 results | 20101010 Health Care Facilities | Income |
| 26 Feb 2026 18:05 CET |
EXPLOSIFS PROD.CHI | Consolidated revenue up 6% to EUR 591.9 million in FY 2025 | 55201000 Chemicals: Diversified | Sales, Income |
| 26 Feb 2026 18:02 CET |
VALEO | Valeo - Résultats annuels 2025 | 40101025 Auto Parts | Other subject |
| 26 Feb 2026 18:02 CET |
VALEO | Valeo - FY 2025 Results | 40101025 Auto Parts | Other subject |
| 26 Feb 2026 18:00 CET |
ABIVAX | ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.01.26. | 20103010 Biotechnology | Share history |
| 26 Feb 2026 18:00 CET |
BONDUELLE | Bonduelle - Chiffre d'affaires et résultats du 1er semestre 2025-2026 - Le Groupe Bonduelle démontre sa résilience dans un contexte particulièrement exigeant | 45102020 Food Products | Income |
| 26 Feb 2026 18:00 CET |
OSE IMMUNOTHERAPEUTICS | OSE Immunotherapeutics Receives Second Positive IDMC Recommendation for Phase 3 ARTEMIA Trial Evaluating Tedopi® in Non-Small Cell Lung Cancer | 20103010 Biotechnology | Other subject |
| 26 Feb 2026 18:00 CET |
GENFIT | GENFIT Reports Fourth Quarter 2025 Financial Information and Provides a Corporate Update | 20103010 Biotechnology | Other subject |
| 26 Feb 2026 18:00 CET |
MINT | Calendrier des publications boursières 2026 | 65101010 Alternative Electricity | Other subject |
| 26 Feb 2026 18:00 CET |
ABIONYX PHARMA | ABIONYX Pharma Provides an Update on Its Business and Cash Position for the 4th Quarter of 2025 | 20103010 Biotechnology | Other subject |
| 26 Feb 2026 18:00 CET |
OSE IMMUNOTHERAPEUTICS | OSE Immunotherapeutics reçoit un deuxième avis positif du Comité Indépendant de Surveillance des Données (IDMC) pour l’essai pivot de Phase 3 ARTEMIA évaluant Tedopi® dans le cancer du poumon non à petites cellules | 20103010 Biotechnology | Other subject |
| 26 Feb 2026 18:00 CET |
BONDUELLE | Bonduelle - 2025-2026 HY1 sales and financial results - The Bonduelle Group demonstrates its resilience in a particulary demanding environment | 45102020 Food Products | Income |
| 26 Feb 2026 18:00 CET |
GENFIT | GENFIT : Information financière du quatrième trimestre 2025 et point sur les activités de la Société | 20103010 Biotechnology | Other subject |
| 26 Feb 2026 18:00 CET |
ABIONYX PHARMA | ABIONYX Pharma fait le point sur son activité et sa position de trésorerie du 4ème trimestre 2025 | 20103010 Biotechnology | Other subject |
| 26 Feb 2026 18:00 CET |
TOUR EIFFEL | Communiqué - Société de la Tour Eiffel - Résultats annuels 2025 - Maintien du cap stratégique et d'une gestion opérationnelle rigoureuse dans un marché exigeant | 35102030 Office REITs | Sales, Income, Commercial results |
| 26 Feb 2026 18:00 CET |
EXPLOSIFS PROD.CHI | Hausse de +6% de l'activité consolidée à 591,9 M EUR en 2025 | 55201000 Chemicals: Diversified | Sales, Income |
| 26 Feb 2026 18:00 CET |
TOUR EIFFEL | Press release - Société de la Tour Eiffel - 2025 Full-Year Results - Maintaining strategic momentum and rigorous operational management in a demanding market | 35102030 Office REITs | Sales, Income, Commercial results |
| 26 Feb 2026 17:59 CET |
SAINT-GOBAIN (COMPAGNIE DE) | Résultats annuels 2025 | 50101035 Building Materials: Other | Income |
| 26 Feb 2026 17:59 CET |
SAINT-GOBAIN (COMPAGNIE DE) | Full-Year 2025 Results | 50101035 Building Materials: Other | Income |
| 26 Feb 2026 17:50 CET |
MACOMPTA.FR | MACOMPTA.FR - Résultats du 1er semestre 25/26 : chiffre d'affaires en hausse de 29 % | 10101015 Software | Sales, Income, Commercial results |
| 26 Feb 2026 17:45 CET |
VIRIDIEN | Viridien : 2025 annual results | 60101030 Oil Equipment and Services | Commercial results |